
A workshop sponsored by the National Cancer Institute and the US Food and Drug Administration addressed past lessons learned and ongoing challenges faced in zzso development and drug and zzso zzso Participants agreed that critical decision points in the product life cycle depend on the level of understanding of the biology of the target and its interaction with the drug, the zzso and zzso factors affecting zzso zzso performance, and the clinical disease zzso The more known about the biology and the greater the strength of association between an zzso signal and clinical result, the more efficient and less risky the development process will zzso Rapid entry into clinical practice will only be achieved by using a rigorous scientific approach, including careful zzso collection and standardized and zzso data zzso Early interaction with appropriate regulatory bodies will ensure studies are appropriately designed and zzso test performance is well zzso 

